ArticleChinese medical journal2026
Non-communicable disease burden in China, 1990-2023: Evidence from the Global Burden of Disease Study 2023.
Article in Chinese medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Application of Large Language Models in Chronic Disease Care: Mixed Methods Systematic Review and Thematic Synthesis.Journal of medical Internet research · 2026Pooled it
- Global and Chinese burden of three major non-communicable diseases attributable to high BMI: trends from 1990 to 2021 and projections to 2050.Tropical medicine and health · 2026Article
- Dynamic reversibility of biological aging and risk of cardiovascular disease and stroke: a longitudinal cohort study.The EPMA journal · 2026Article
- Incidence, DALYs, and death rates of chronic kidney disease in China, 1990-2023: Results from the Global Burden of Disease Study 2023.Chinese medical journal · 2026Article
- Integrin α5β1 in pancreatic ductal adenocarcinoma: Tumour‒stroma crosstalk, hypoxia and therapeutic targeting.Clinical and translational medicine · 2026Review
- Population aging and changes in mortality from four major noncommunicable diseases in Suzhou, China: a population-based study from 2000 to 2020.BMC public health · 2026Article
- Waist circumference shows a significant association with the risk of noncommunicable diseases: a cross-sectional study from a large community sample in Southeast China.BMC public health · 2026Article
- Associations of cumulative exposure and longitudinal change patterns of the triglyceride glucose-Chinese visceral adiposity index with incident cardiovascular disease in middle-aged and older adults: evidence from CHARLS.Cardiovascular diabetology · 2026Observational
- Cost-Effectiveness of Internet of Things-Based Management of Home Noninvasive Positive Pressure Ventilation in Patients With Chronic Obstructive Pulmonary Disease and Hypercapnic Chronic Respiratory Failure: Trial-Based Economic Evaluation.JMIR mHealth and uHealth · 2026Article
- National trends in acute viral hepatitis in China from 1990-2023: An analysis of the Global Burden of Disease 2023 update.Chinese medical journal · 2026Article
- Global burden of ischemic heart disease from 1990 to 2021: Findings from the Global Burden of Disease Study 2021 and predictions to 2030.Chinese medical journal · 2026Article
- Comparison of national health planning policies in China and ASEAN: a PMC-index model analysis.Cost effectiveness and resource allocation : C/E · 2026Article
- Burden and temporal trends of non-communicable diseases from 1990 to 2021 and prediction to 2035 in the group of twenty countries: a systematic analysis of the Global Burden of Disease Study 2021.Frontiers in microbiology · 2026Article
- Multimodal risk profiles reveal shared and disease-specific risks of major non-communicable diseases: a prospective cohort study of 42,666 individuals.International journal of public health · 2026Article
- Temporal Trends and Future Projections of Oral Disorders Among Women of Childbearing Age in South Korea.International journal of women's health · 2026Article
- The national and provincial disease and indirect economic burden of high alcohol use in China from 1990 to 2023 with forecasting to 2050.Military Medical Research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNon-communicable diseases (NCDs) are the leading cause of disease burden worldwide. Amid rapid population aging, China faces a substantial NCD burden. This study aimed to assess the NCD burden in China in 2023 using data from the Global Burden of Disease Study 2023.
methodsThis study used data from the Global Burden of Disease Study 2023, which covers 31 provinces in Chinese mainland and the Hong Kong and Macao Special Administrative Regions. Age-standardized and all-age mortality and disability-adjusted life year (DALY) rates for NCDs were estimated and compared between 1990 and 2023. Analyses were conducted according to sex, age group, and region. Level 3 NCD causes were ranked according to mortality and DALY rates.
resultsNCDs were the major contributor to China's disease burden in 2023. Cardiovascular diseases (316.08/100,000), neoplasms (180.02/100,000), and chronic respiratory diseases (73.15/100,000) were the leading causes of NCD-related mortality rates. Cardiovascular diseases (6262.68/100,000) and neoplasms (4456.46/100,000) were the top contributors to DALY rates. Age-standardized mortality and DALY rates for major NCDs have declined since 1990; however, the absolute numbers continue to rise because of population aging. Notable increases in disease burden were observed. Compared to 1990, the mortality rate increased by 239.14% and the DALY rate by 77.04% for neurological disorders. For mental disorders, mortality increased by 382.34% and the DALY rate by 25.82%. For musculoskeletal disorders, the DALY rate increased by 48.17%. Geographic disparities persisted, with higher NCD burdens concentrated in the western and northeastern provinces, whereas the more developed eastern regions showed relatively lower rates.
conclusionsNCDs remain the leading cause of disease burden in China and vary significantly by disease type, sex, age, and region. Strengthening prevention, improving the management of high-risk populations, and enhancing data accuracy are essential for more effective and equitable NCD control.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.